Table 9.
The influence of biocomposite implants administration on the elements of the leucocyte formula. Values were presented as mean ± S.D. for six animals in a group.
| Groups | Leucocyte Formula (% Values) | |||||
|---|---|---|---|---|---|---|
| PMN | Ly | E | M | B | ||
| Control | 24 h | 29.5 ± 0.83 | 66.3 ± 2.11 | 0.6 ± 0.08 | 3.4 ± 0.10 | 0.2 ± 0.10 |
| 7 days | 29.7 ± 0.47 | 65.9 ± 1.93 | 0.7 ± 0.10 | 3.5 ± 0.10 | 0.2 ± 0.05 | |
| PLA/PEG | 24 h | 29.8 ± 0.89 | 65.7 ± 1.39 | 0.7 ± 0.10 | 3.6 ± 0.05 | 0.2 ± 0.04 |
| 7 days | 29.9 ± 0.55 | 65.5 ± 1.63 | 0.7 ± 0.05 | 3.7 ± 0.12 | 0.2 ± 0.05 | |
| PLA/PEG/3CS | 24 h | 29.1 ± 0.37 | 66.7 ± 2.14 | 0.6 ± 0.08 | 3.4 ± 0.05 | 0.2 ± 0.05 |
| 7 days | 29.4 ± 0.98 | 66.1 ± 1.33 | 0.8 ± 0.1 | 3.5 ± 0.08 | 0.2 ± 0.05 | |
| PLA/PEG/6CS | 24 h | 29.3 ± 0.72 | 66.3 ± 1.55 | 0.7 ± 0.05 | 3.5 ± 0.08 | 0.2 ± 0.04 |
| 7 days | 29.5 ± 0.65 | 66.1 ± 2.04 | 0.7 ± 0.08 | 3.5 ± 0.05 | 0.2 ± 0.05 | |
| PLA/PEG/0.5R | 24 h | 29.8 ± 0.27 | 65.7 ± 1.98 | 0.6 ± 0.10 | 3.7 ± 0.10 | 0.2 ± 0.05 |
| 7 days | 29.9 ± 1.63 | 65.4 ± 1.47 | 0.8 ± 0.13 | 3.7 ± 0.05 | 0.2 ± 0.05 | |
| PLA/PEG/3CS/0.5R | 24 h | 29.5 ± 0.45 | 66.1 ± 1.39 | 0.7 ± 0.08 | 3.5 ± 0.1 | 0.2 ± 0.04 |
| 7 days | 29.2 ± 0.69 | 66.2 ± 1.72 | 0.8 ± 0.05 | 3.6 ± 0.08 | 0.2 ± 0.05 | |
| PLA/PEG/6CS/0.5R | 24 h | 29.6 ± 0.33 | 66.0 ± 1.89 | 0.8 ± 0.1 | 3.4 ± 0.08 | 0.2 ± 0.05 |
| 7 days | 29.7 ± 0.47 | 65.9 ± 1.37 | 0.7 ± 0.08 | 3.5 ± 0.1 | 0.2 ± 0.05 | |
*PMN—polymorphonuclear neutrophils, Ly—lymphocytes, E—eosinophils, M—monocytes, and B—basophils.